Latest filing published 06 Apr 2026 for AGIOS PHARMACEUTICALS, INC., €89k. Read the official filing
No signal scores available.
This profile gathers the share dealings of Krishnan Viswanadhan in Agios Pharmaceuticals, Inc. Between 5 March 2026 and 2 April 2026, the trades on record add up to 3 filings.
No open-market purchase appears, only 1 sale worth €89k. Other entries cover 2 option exercises.
The latest filing, published on 6 April 2026, reports an open-market sale of €89k in Agios Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations